SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-044947
Filing Date
2006-03-03
Accepted
2006-03-03 14:31:15
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1095512
2 EMPLOYMENT AGREEMENT dex1022.htm EX-10.22 363948
3 AGREEMENT OF PURCHASE AND SALE BETWEEN THE REGISTRANT AND BIOMED REALTY, L.P. dex1023a.htm EX-10.23(A) 200167
4 LEASE AGREEMENT dex1023b.htm EX-10.23(B) 167399
5 COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES dex121.htm EX-12.1 24219
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2186
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8894
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8957
9 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 4439
10 GRAPHIC g73429image001.jpg GRAPHIC 7052
  Complete submission text file 0001193125-06-044947.txt   1886908
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 06663187
SIC: 2836 Biological Products, (No Diagnostic Substances)